Delayed Effects of AST-120 on Chronic Cyclosporin Nephrotoxicity.

被引：0
|
作者：
Kim, Su Hyun [1 ]
Ghee, Jung Yeon [2 ]
Piao, ShangGuo [2 ]
Song, Hyun Kuk [2 ]
Han, Dong He [2 ]
Song, Ji-Hyun [2 ]
Yoon, Hye Eun [2 ]
Choi, Bum Soon [2 ]
Kim, Yong Soo [2 ]
Nishijima, Fuyuhiko [3 ]
Obara, Kazumi [3 ]
Ishikawa, Noriyuki [3 ]
Yang, Chul-Woo [2 ]
机构：
[1] Chung Ang Univ, Dept Internal Med, Seoul 156756, South Korea
[2] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea
[3] Kureha Corp, Biomed Res Labs, Tokyo, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：635 / 635
页数：1
相关论文
共 50 条
  • [21] Effects of oral adsorbent ast-120 (Kremezin) on progression of chronic renal disease in patients with or without diabetes
    Park, Hyeong Cheon
    Sim, Soung Rok
    Lee, Sang Hun
    Kim, Ki Joong
    Park, Woo Il
    Ha, Sung Kyu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 388 - 388
  • [22] EFFECTS OF AST-120 ON CARDIORENAL SYNDROME IN MYOCARDIAL INFARCTION MODEL RATS
    Fujii, Hideki
    Yamashita, Yusuke
    Yonekura, Yuriko
    Nakai, Kentaro
    Kono, Keiji
    Goto, Shunsuke
    Sugano, Mikio
    Goto, Sumie
    Ito, Yoshiharu
    Nishi, Shinichi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 410 - 410
  • [23] Molecular insights into preventive effects of AST-120 on the progression of renal failure
    Aoyama I.
    Niwa T.
    Clinical and Experimental Nephrology, 2001, 5 (4) : 209 - 216
  • [24] Effects of AST-120 on mortality in patients with chronic kidney disease modeled by artificial intelligence or traditional statistical analysis
    Chia-Lin Lee
    Wei‑Ju Liu
    Shang-Feng Tsai
    Scientific Reports, 14
  • [25] Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
    Gerald Schulman
    Tomas Berl
    Gerald J. Beck
    Giuseppe Remuzzi
    Eberhard Ritz
    Miho Shimizu
    Mami Kikuchi
    Yuko Shobu
    Clinical and Experimental Nephrology, 2018, 22 : 299 - 308
  • [26] Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
    Liu, Wen-Chih
    Tomino, Yasuhiko
    Lu, Kuo-Cheng
    TOXINS, 2018, 10 (09)
  • [27] Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats
    Tan, Xiao
    He, Jianqiang
    Cao, Xuesen
    Zou, Jianzhou
    Liu, Hong
    Ding, Xiaoqiang
    RENAL FAILURE, 2015, 37 (02) : 337 - 342
  • [28] Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
    Velenosi, Thomas J.
    Hennop, Anzel
    Feere, David A.
    Tieu, Alvin
    Kucey, Andrew S.
    Kyriacou, Polydoros
    McCuaig, Laura E.
    Nevison, Stephanie E.
    Kerr, Michael A.
    Urquhart, Bradley L.
    SCIENTIFIC REPORTS, 2016, 6
  • [29] Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients
    Asai, Mayumi
    Kumakura, Sei
    Kikuchi, Mami
    RENAL FAILURE, 2019, 41 (01) : 47 - 56
  • [30] Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
    Schulman, Gerald
    Berl, Tomas
    Beck, Gerald J.
    Remuzzi, Giuseppe
    Ritz, Eberhard
    Shimizu, Miho
    Kikuchi, Mami
    Shobu, Yuko
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (02) : 299 - 308
12345